Literature DB >> 33552479

The Role of Life Style Modifications in Comprehensive Non-Alcoholic Fatty Liver Disease Treatment.

Kathleen Viveiros1.   

Abstract

Watch a video presentation of this article Watch an interview with the author.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2021        PMID： 33552479      PMCID： PMC7849295          DOI： 10.1002/cld.1007

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  10 in total

Review 1.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

2.  Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.

Authors:  Jeffrey W Molloy; Christopher J Calcagno; Christopher D Williams; Frances J Jones; Dawn M Torres; Stephen A Harrison
Journal:  Hepatology       Date:  2011-12-22       Impact factor: 17.425

Review 3.  Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa?

Authors:  N R W Geiker; A Astrup; M F Hjorth; A Sjödin; L Pijls; C Rob Markus
Journal:  Obes Rev       Date:  2017-08-28       Impact factor: 9.213

4.  Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.

Authors:  Eduardo Vilar-Gomez; Yadina Martinez-Perez; Luis Calzadilla-Bertot; Ana Torres-Gonzalez; Bienvenido Gra-Oramas; Licet Gonzalez-Fabian; Scott L Friedman; Moises Diago; Manuel Romero-Gomez
Journal:  Gastroenterology       Date:  2015-04-10       Impact factor: 22.682

5.  Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.

Authors:  Hyun-Suk Jung; Yoosoo Chang; Min-Jung Kwon; Eunju Sung; Kyung Eun Yun; Yong Kyun Cho; Hocheol Shin; Seungho Ryu
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

6.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Authors:  Kittichai Promrat; David E Kleiner; Heather M Niemeier; Elizabeth Jackvony; Marie Kearns; Jack R Wands; Joseph L Fava; Rena R Wing
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 7.  Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum.

Authors:  Oliver Glass; Claudia Filozof; Mazen Noureddin; Mark Berner-Hansen; Elmer Schabel; Stephanie O Omokaro; Jörn M Schattenberg; Katherine Barradas; Veronica Miller; Sven Francque; Manal F Abdelmalek
Journal:  J Hepatol       Date:  2020-04-27       Impact factor: 25.083

Review 8.  Lifestyle modification in NAFLD/NASH: Facts and figures.

Authors:  Kate Hallsworth; Leon A Adams
Journal:  JHEP Rep       Date:  2019-11-05

9.  Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review.

Authors:  Susan Kenneally; Joanna H Sier; J Bernadette Moore
Journal:  BMJ Open Gastroenterol       Date:  2017-06-01

Review 10.  Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.

Authors:  Mikiko Watanabe; Rossella Tozzi; Renata Risi; Dario Tuccinardi; Stefania Mariani; Sabrina Basciani; Giovanni Spera; Carla Lubrano; Lucio Gnessi
Journal:  Obes Rev       Date:  2020-03-24       Impact factor: 9.213
  10 in total
  3 in total

1.  Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism.

Authors:  Khaoula Errafii; Olfa Khalifa; Neyla S Al-Akl; Abdelilah Arredouani
Journal:  Biomedicines       Date:  2022-04-28

Review 2.  Anthocyanins: Traditional Uses, Structural and Functional Variations, Approaches to Increase Yields and Products' Quality, Hepatoprotection, Liver Longevity, and Commercial Products.

Authors:  Hamdoon A Mohammed; Riaz A Khan
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

Review 3.  Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Authors:  Priyanka Bhandari; Amit Sapra; Mohitkumar S Ajmeri; Christine E Albers; Devanshika Sapra
Journal:  Cureus       Date:  2022-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.